Related Experiment Video
Updated: Jul 18, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Alternative splicing events and function in the tumor microenvironment: New opportunities and challenges
Xueyi Song1, Xuehao Li2, Yuexin Ge1
1Department of Pharmacology, School of Pharmacy, China Medical University, Shenyang 110122, PR China; Liaoning Key Laboratory of molecular targeted anti-tumor drug development and evaluation, China Medical University, Shenyang 110122, PR China.
Alternative splicing, a key gene expression regulator, impacts cancer metastasis. This review explores its role in the tumor microenvironment, offering insights into cancer therapeutics and prognostic markers.
Area of Science:
- Molecular Biology
- Cancer Biology
- Immunology
Background:
- Alternative splicing regulates gene expression, producing diverse protein isoforms.
- Aberrant alternative splicing is implicated in cancer development, invasion, and metastasis.
- Emerging evidence links alternative splicing to tumor microenvironment modulation, including remodeling, immunity, and inflammation.
Purpose of the Study:
- To comprehensively review the intricate relationship between alternative splicing and the tumor microenvironment.
- To consolidate recent findings on how alternative splicing influences tumor microenvironment dynamics.
- To identify potential therapeutic targets and prognostic biomarkers based on alternative splicing.
Main Methods:
- Literature review of recent studies on alternative splicing and the tumor microenvironment.
- Analysis of data linking alternative splicing events to cancer progression and microenvironment features.
- Synthesis of information to provide a novel perspective on cancer treatment and prognosis.
Main Results:
- Alternative splicing significantly impacts cancer cell behavior and the tumor microenvironment.
- Specific splicing variants can promote or inhibit tumor invasion and metastasis.
- Alternative splicing influences immune cell function and inflammatory responses within the tumor.
Conclusions:
- Alternative splicing is a critical factor in cancer progression and the tumor microenvironment.
- Understanding these complex interactions can lead to novel cancer therapies.
- Alternative splicing alterations represent promising avenues for cancer biomarker development.
Related Concept Videos
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing
The Tumor Microenvironment
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Immunotherapy

